Becton, Dickinson and Company (BD) has completed its acquisition of Cellular Research, a biotechnology R&D company. Cellular Research has developed advanced tools for massively parallel single cell genetic analysis based on their proprietary molecular indexing technology to enable gene expression profiles from single cells.

Combined, the BD and Cellular Research technologies provide researchers an integrated sample prep workflow to quantify and study gene expression in large numbers of individual cells, enabling higher resolution biology. The comprehensive workflow is intended to enable researchers to make new discoveries in single cell analysis, promoting the understanding of the genomic diversity of single cells and helping to identify new approaches for targeted clinical diagnostics and therapies in important fields such as immunology, immune-oncology and personalized medicine.

Since September 2014, BD and Cellular Research have had a collaboration to develop single cell analysis workflows for Cellular Research’s Precise product line and BD’s FACS instruments and software.